Cori Campbell
Cori Campbell
Nuffield Department of Medicine, University of Oxford
Verified email at - Homepage
Cited by
Cited by
Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta‐analysis
C Campbell, T Wang, AL McNaughton, E Barnes, PC Matthews
Journal of viral hepatitis 28 (3), 493-507, 2021
Risk of reactivation of hepatitis B virus (HBV) and tuberculosis (TB) and complications of hepatitis C virus (HCV) following tocilizumab therapy: a systematic review to inform …
C Campbell, MI Andersson, MA Ansari, O Moswela, SA Misbah, ...
Frontiers in Medicine, 1346, 2021
Acute Severe Hepatitis Outbreak in Children: A Perfect Storm What do we know, and what questions remain?
PC Matthews, C Campbell, A Rivero-Juarez, BJ Van Welzen, BK Tan, ...
Frontiers in Pharmacology, 4909, 2022
Impaired humoral and cellular response to primary COVID‐19 vaccination in patients less than 2 years after allogeneic bone marrow transplant
SM Murray, M Barbanti, C Campbell, A Brown, L Chen, J Dhanapal, ...
British Journal of Haematology 198 (4), 668-679, 2022
Evaluation of disruptive camouflage of avian cup‐nests
T Mulder, CJ Campbell, GD Ruxton
Ibis 163 (1), 150-158, 2021
Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
T Wang, DA Smith, C Campbell, J Mokaya, O Freeman, H Salih, ...
BMC infectious diseases 21 (1), 1-14, 2021
Cohort Profile: National Institute for Health Research Health Informatics Collaborative: Hepatitis B Virus (NIHR HIC HBV) Research Dataset
T Wang, DA Smith, C Campbell, O Freeman, Z Moysova, T Noble, ...
International Journal of Epidemiology, 1-11, 2022
Longitudinal analysis of the utility of liver biochemistry as prognostic markers in hospitalized patients with corona virus disease 2019
T Wang, DA Smith, C Campbell, S Harris, H Salih, KA Várnai, K Woods, ...
Hepatology Communications 5 (9), 1586-1604, 2021
Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing?[version 1; peer review: 1 approved, 2 approved with …
C Campbell, T Wang, R Burrow, S Mandal, J Hippisley-Cox, E Barnes, ...
Wellcome Open Research 7, 2022
A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy
LO Downs, C Campbell, P Yonga, MA Ansari, PC Matthews, AO Etyang
medRxiv, 2022
Development and validation of personalised risk prediction models for early detection and diagnosis of primary liver cancer among the English primary care population using the …
W Liao, P Jepsen, C Coupland, H Innes, PC Matthews, C Campbell, ...
medRxiv, 2022
Impact of the COVID-19 pandemic on routine surveillance for adults with chronic hepatitis B virus (HBV) infection in the UK.
C Campbell, T Wang, DA Smith, O Freeman, T Noble, KA Várnai, S Harris, ...
medRxiv, 2021
Disparities in care and outcomes for primary liver cancer in England during 2008–2018: a cohort study of 8.52 million primary care population using the QResearch database
W Liao, CAC Coupland, H Innes, P Jepsen, PC Matthews, C Campbell, ...
EClinicalMedicine 59, 2023
Baseline characteristics of a large multi-site chronic HBV electronic health record-based cohort in the UK
C Campbell, T Wang, E Barnes, PC Matthews, C Campbell, T Wang
The International Liver Congress 2021, 1158, 2021
Analysis of primary care electronic health record data of people living with hepatitis B virus: infection and hepatocellular carcinoma risk associated with socio-economic …
PCM C. Campbell, T. Wang, I. Gillespie, E. Barnes
Public Health 226, 215-227, 2024
Where Do Those Data Go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya
LO Downs, C Campbell, M Abouyannis, M Otiende, M Kapulu, CW Obiero, ...
Journal of Virus Eradication, 100355, 2023
A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) genotypic resistance in people treated with entecavir or tenofovir
SF Lumley, M Delphin, JF Mokaya, CCS Tan, E Martyn, M Anderson, ...
medRxiv, 2023.11. 08.23298154, 2023
Novel serum biomarkers for risk stratification in chronic hepatitis B-what do they bring to the table?
L Downs, M Delphin, T Wang, C Campbell, S Lumley, E Waddilove, ...
Journal of Hepatology 78, S1060, 2023
Distinct virologic trajectories in chronic hepatitis B patients identify heterogeneity in response to nucleotide analogue therapy
T Wang, C Campbell, G Roadknight, S Little, A Stockdale, S Todd, ...
Journal of Hepatology 78, S1075-S1076, 2023
Contrasting immune fingerprints of chronic hepatitis B Virus infection in adults from South Africa and the United Kingdom
M Delphin, L Downs, E Martyn, G Kelly, M Van Schalkwyk, S Hugo, ...
Journal of Hepatology 78, S1108-S1109, 2023
The system can't perform the operation now. Try again later.
Articles 1–20